Badaj.Tosp. z o.o.

Independent medical laboratory activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-03-25
Share capital
95 000,00 PLN
Registered address
ul. Wojska Polskiego 16H, 41-600 Świętochłowice, Poland
Electronic delivery address
AE:PL-96355-70918-CEVIV-32

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 38.87mMedianUSD 1.19mAverageUSD 20.98m
Net profit
This companyUSD 4.28mMedianUSD 101.78kAverageUSD 1.28m
Operating costs
This companyUSD 33.17mMedianUSD 1.08mAverageUSD 18.94m
Assets
This companyUSD 21.61mMedianUSD 1.07mAverageUSD 11.99m

Bank accounts

Registered as a VAT taxpayer on 1993-07-05. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$109.3K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$359.5K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,222

European Funds

ProjectEU co-financing
BADAJ.TO zdrowy pracownik i zdrowa organizacja
$141.6K

Tenders

1 tender recorded as contractor, with a total value of $15,162.

SubjectAmount
Świadczenie Usług zdrowotnych z zakresu badań laboratoryjnych w ramach projektu „Zdrowa Psyche”, współfinansowanego przez Unię Europejską ze środków Europejskiego Funduszu Społecznego Plus [...]
$15,162

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Authorized Representatives

Beata Anna Boruta — Management Board Member
Bartosz Mrzyczek — Management Board Member
Łukasz Pawlik — President of the Management Board

Manner of representation

1. In the case of a one-person management board, the sole member of the management board, irrespective of the function held in the management board, is authorised to represent the company independently and make declarations of will on its behalf. 2. In the case of a multi-member management board, the President of the Management Board is authorised to represent the company independently and make declarations of will on its behalf. 3. In the case of a multi-member management board, the other members of the management board, except for the President of the Management Board, are authorised to represent the company independently in the scope of: a) activities connected with the current operation of the company’s enterprise up to PLN 300,000.00 (three hundred thousand zlotys); b) entering into agreements connected with the company’s activities, in the case of: - agreements concluded for a period shorter than 6 (six) months, if the total amount of the company’s obligations for the entire term of the agreement does not exceed PLN 300,000.00 (three hundred thousand zlotys); - agreements concluded for a period longer than 6 (six) months, if the total amount of the company’s obligations for the 6 (six) months of the agreement’s term does not exceed PLN 300,000.00 (three hundred thousand zlotys); c) making declarations and signing in respect of offers, including tender offers, submitted by the company to the National Health Fund as well as public and non-public health care units, in particular medical entities, medical establishments, care and treatment establishments, laboratories, and scientific and research units. 4. In the case of a multi-member management board, the other members of the management board, except for the President of the Management Board, are authorised to represent the company only jointly with the President of the Management Board in matters not specified in paragraph 3, in particular: a) acquisition, disposal or encumbrance of ownership of real property or a part thereof; b) acquisition, disposal or encumbrance of the right of perpetual usufruct of real property; c) entering into loan, borrowing and leasing agreements; d) conducting investment activities by the company, in particular entering into agreements for the use or renovation of premises.

Ownership

OwnerSharesShare valueStake
Intermed International Beteiligungsgesellschaft Gmbh & Co. Kg
58$14,883.8558%
Marcel Tomasz Jarasch (32)
36$9,238.2536%
Others
6$1,539.716%

Beneficial owners

10 beneficial owners recorded in CRBR.

Person
Christine Bennett (70)
Mark Raymond Compton (65)
Suzanne Crowe (75)
Nicola Mai Wakefield Evans (66)
Thomas Jarasch (58)
Katharine Mchenry (48)
Neville John Mitchell (67)
James Pacey Newcombe (47)

Subsidiaries

NameStake
75%
LADR Immobiliensp. z o.o.
100%
100%

Change history

DateEvent
2025-11-21PKD change
2022-05-30Address change
2019-12-18Name change
2018-05-11PKD change
2013-10-01PKD change

FAQ

Last updated: 2026-07-16